Decreased incidence of cytomegalovirus infection in thymoglobulin-treated transplant patients with 6 months of valganciclovir prophylaxis

Am J Transplant. 2004 Jan;4(1):148-9. doi: 10.1046/j.1600-6143.2003.00308.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antilymphocyte Serum / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Clinical Trials as Topic
  • Cytomegalovirus Infections / epidemiology*
  • Female
  • Ganciclovir / analogs & derivatives*
  • Ganciclovir / therapeutic use*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Organ Transplantation / adverse effects*
  • Organ Transplantation / methods*
  • Time Factors
  • Valganciclovir

Substances

  • Antilymphocyte Serum
  • Antiviral Agents
  • Valganciclovir
  • Ganciclovir